AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 28729302
Drug: Vosaroxin 70
RxNorm normalized name: vosaroxin
DrugBank: Vosaroxin (DB11999)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vosaroxin 70 mg/m2
Trial: 15493565
Drug: recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: recombinant human follicle-stimulating hormone (rFSH)
Trial: 9255748
Drug: No hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No hormone replacement therapy
Trial: 8291388
Drug: Titrated sufentanil-midazolam
RxNorm normalized name: Sufentanil Citrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Titrated sufentanil-midazolam infusion
Trial: 8291388
Drug: Standard postoperative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard postoperative analgesia with intravenous increments of morphine and midazolam
Trial: 2872429
Drug: No tocolytic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No tocolytic treatment (Control)
Trial: 30192782
Drug: GR-MD-02 (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GR-MD-02 (8 mg.kg-1 via IV infusion, biweekly for 16 weeks)
Trial: 27100898
Drug: Low-dose alcohol
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose alcohol (0.02 g/100 ml blood alcohol concentration)
Trial: 22437449
Drug: Lacosamide 50
RxNorm normalized name: lacosamide 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lacosamide 50 mg single dose
Trial: 22437449
Drug: Lacosamide 100
RxNorm normalized name: lacosamide 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lacosamide 100 mg twice daily
Trial: 22437449
Drug: Lacosamide 200
RxNorm normalized name: lacosamide 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lacosamide 200 mg twice daily
Trial: 18367682
Drug: Voice Production
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Voice Production Therapy (VP)
Trial: 18367682
Drug: Voice Production
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Voice Production Therapy (VP) with self-study
Trial: 15726579
Drug: Piribedil (2-16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piribedil (2-16 mg)
Trial: 15726579
Drug: Piribedil (16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piribedil (16 mg)
Trial: 8282330
Drug: Angiotensin II
RxNorm normalized name: Angiotensin II
DrugBank: Angiotensin II (DB11842)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Angiotensin II (Ang II) infusion
Trial: 10517737
Drug: Candesartan (inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candesartan (inhibitor of Ang II AT1 receptor)
Trial: 9052891
Drug: Losartan (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan (50 mg UID)
Trial: 10517737
Drug: Atenolol (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol (50 mg UID)
Trial: 7861022
Drug: Zidovudine administered
RxNorm normalized name: Zidovudine
DrugBank: Zidovudine (DB00495)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zidovudine administered to women after the first trimester
Trial: 7861022
Drug: Antiretroviral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiretroviral therapy in zidovudine-experienced patients with <50 CD4 cells/mm3
Trial: 1873448
Drug: Vitamin A,
RxNorm normalized name: Vitamin A, D
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin A, 25,000 IU; beta-carotene, 50 mg; vitamin E, 800 IU; selenium, 400 micrograms (administered daily)
Trial: 1873448
Drug: Placebos (administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebos (administered daily)
Trial: 31915235
Drug: VA-dual therapy
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VA-dual therapy (vonoprazan 20 mg + amoxicillin 750 mg twice/day)
Trial: 31915235
Drug: VAC-triple therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VAC-triple therapy (vonoprazan 20 mg + amoxicillin 750 mg + clarithromycin 200 mg twice/day)
Trial: 17453967
Drug: 4 days
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 days of G-CSF administration
Trial: 17453967
Drug: 6 days
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 days of G-CSF administration
Trial: 18084873
Drug: Fluvoxamine 50
RxNorm normalized name: fluvoxamine 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvoxamine 50 mg/day
Trial: 3724308
Drug: Flunitrazepam 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flunitrazepam 1.5 mg
Trial: 2692145
Drug: Prolonged antithrombotic
RxNorm normalized name: antithrombin III
DrugBank: Antithrombin III human (DB11598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prolonged antithrombotic treatment with anticoagulants or antiplatelet drugs (50 mg aspirin + 400 mg dipyridamole daily)
Trial: 2692145
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment after 3 months of active therapy
Trial: 1096538
Drug: Piracetam 4.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piracetam 4.8 g/day for 3 days
Trial: 28770409
Drug: Trigger Point
RxNorm normalized name: ActivOn Joint & Muscle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trigger Point (TP) therapy alone
Trial: 28770409
Drug: Trigger Point
RxNorm normalized name: ActivOn Joint & Muscle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trigger Point (TP) therapy combined with Lymphatic Drainage (LD)
Trial: 25998450
Drug: Neridronate 100
RxNorm normalized name: etidronate
DrugBank: Etidronic acid (DB01077)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Neridronate 100 mg given four times over 10 days
Trial: 21842171
Drug: sugammadex (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sugammadex (2 mg/kg)
Trial: 21842171
Drug: neostigmine (0.04
FDA approved: no
EMA approved: no
PMDA approved: no
Description: neostigmine (0.04 mg/kg)
Trial: 19024312
Drug: Pulmonary static
RxNorm normalized name: Lobaria pulmonaria extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulmonary static inflation during CPB, no sevoflurane inhaled
Trial: 10755499
Drug: E5 (murine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E5 (murine monoclonal antibody directed against endotoxin, 2 mg/kg per day by intravenous infusion 24 hours apart)
Trial: 1421737
Drug: Lidocaine 70
RxNorm normalized name: lidocaine 70 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine 70 mg
Trial: 3903784
Drug: 1.5 g
RxNorm normalized name: Vaporizer Vicks 1.5 gal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 g triletide per day
Trial: 3903786
Drug: 1.2 g
RxNorm normalized name: Humidifier 1.2 gallon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.2 g cimetidine per day
Trial: 31639529
Drug: FORNET (adapted
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FORNET (adapted Narrative Exposure Therapy)
Trial: 18058305
Drug: Betamethasone %1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Betamethasone %1 cream
Trial: 18058305
Drug: Unna's Boot
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unna's Boot cream
Trial: 15851794
Drug: Epoetin alfa
RxNorm normalized name: epoetin alfa
DrugBank: Erythropoietin (DB00016)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epoetin alfa therapy
Trial: 9802367
Drug: Budesonide 200
RxNorm normalized name: budesonide 200 mcg/inh inhalation powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide 200 micro(g) once daily
Trial: 9802367
Drug: Mometasone furoate
RxNorm normalized name: Mometasone Furoate
DrugBank: Mometasone furoate (DB14512)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mometasone furoate (MF) 200 micro(g) once daily
Trial: 9802367
Drug: Triamcinolone acetonide
RxNorm normalized name: Triamcinolone Acetonide
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Triamcinolone acetonide (TAA) 220 micro(g) once daily
Trial: 7713046
Drug: F2 (2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: F2 (2.0 g/100 ml protein formula)
Trial: 7713046
Drug: F1.5 (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: F1.5 (1.5 g/100 ml protein formula)
Trial: 28259556
Drug: Moxidectin pour-on
RxNorm normalized name: doramectin
DrugBank: Doramectin (DB11400)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moxidectin pour-on (Cydectin® 0.5% Pour-On, Zoetis) administered during the dry period (7–77 days before parturition) to 638 animals
Trial: 26012937
Drug: Salmon calcitonin
RxNorm normalized name: Salmon calcitonin
DrugBank: Salmon calcitonin (DB00017)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmon calcitonin treatment in addition to calcium and vitamin D (Group I)
Trial: 23571802
Drug: Percutaneous irradiation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Percutaneous irradiation therapy
Trial: 22462232
Drug: Oral entecavir
RxNorm normalized name: Entecavir
DrugBank: Entecavir (DB00442)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral entecavir
Trial: 19198872
Drug: Fluid controlling
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluid controlling hormones (Antidiuretic hormone and aldosterone)
Trial: 16432056
Drug: Antithrombotic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antithrombotic therapy (Warfarin or Aspirin)
Trial: 9045347
Drug: Carboplatin administered
RxNorm normalized name: Carboplatin
DrugBank: Carboplatin (DB00958)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Carboplatin administered over 30 minutes and paclitaxel over 3 hours, every 4 weeks
Trial: 9045347
Drug: Increasing paclitaxel
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Increasing paclitaxel doses from 100 to 250 mg/m2
Trial: 7904761
Drug: ipsapirone (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ipsapirone (10 mg to 30 mg daily)
Trial: 7904761
Drug: lorazepam (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lorazepam (2 mg to 6 mg daily)
Trial: 30765508
Drug: Omipalisib (0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omipalisib (0.25 mg, 1 mg, and 2 mg twice daily for 8 days)
Trial: 30073929
Drug: PEM therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PEM therapy (Serrazyme and other constituents) for 2 months
Trial: 19770635
Drug: Capecitabine (2000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capecitabine (2000 mg/m/day for 14 days, once every 3 weeks) plus erlotinib (150 mg/day)
Trial: 19770635
Drug: Gemcitabine (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine (1000 mg/m as a 30-min infusion) plus erlotinib (150 mg/day)
Trial: 16037756
Drug: Phytoestrogen-containing supplement
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phytoestrogen-containing supplement (soy isoflavones and Actaea racemosa)
Trial: 10460765
Drug: Double patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Double patch with tape
Trial: 10460765
Drug: No patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No patch with tape
Trial: 8532911
Drug: Radiotherapy plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiotherapy plus hormone therapy
Trial: 2092324
Drug: calcitonin (415
FDA approved: no
EMA approved: no
PMDA approved: no
Description: calcitonin (415 pmol i.v. bolus + continuous infusion during 90 min to reach an overall dose of 62.25 pmol.kg‐1 body mass)
Trial: 353458
Drug: Spironolactone (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spironolactone (50 mg twice a day)
Trial: 353458
Drug: Hydrochlorothiazide (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide (50 mg twice a day)
Trial: 353458
Drug: Spironolactone +
RxNorm normalized name: Spironolactone
DrugBank: Spironolactone (DB00421)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Spironolactone + alpha-methyldopa (250 mg three times a day)
Trial: 353458
Drug: Hydrochlorothiazide +
RxNorm normalized name: Hydrochlorothiazide
DrugBank: Hydrochlorothiazide (DB00999)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide + alpha-methyldopa (250 mg three times a day)
Trial: 30509553
Drug: iCook 4-H
RxNorm normalized name: egg shell, cooked
FDA approved: no
EMA approved: no
PMDA approved: no
Description: iCook 4-H treatment group
Trial: 19040678
Drug: Divalproex sodium
RxNorm normalized name: Divalproex Sodium
DrugBank: Valproic acid (DB00313)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Divalproex sodium extended-release 1000 mg daily after initial 500 mg for 15 days
Trial: 17062029
Drug: Pulse itraconazole
RxNorm normalized name: Itraconazole
DrugBank: Itraconazole (DB01167)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pulse itraconazole (200 mg twice daily, 1 week on, 3 weeks off, for 12 weeks)
Trial: 17062029
Drug: Continuous terbinafine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous terbinafine (250 mg once daily for 12 weeks)
Trial: 9666777
Drug: Transurethral alprostadil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transurethral alprostadil therapy
Trial: 3261548
Drug: Nifedipine 10
RxNorm normalized name: nifedipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine 10 mg administered sublingually one minute before anaesthetic induction
Trial: 28807988
Drug: High-flow nasal
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-flow nasal cannula (flow 50 L/min, FIO2 0.5)
Trial: 25055809
Drug: Pre-treatment cortico-striatal
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre-treatment cortico-striatal connectivity
Trial: 22006106
Drug: Internet-based cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet-based cognitive behavioral therapy for 5 weeks
Trial: 16457716
Drug: Buprenorphine patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine patch
Trial: 14510796
Drug: Contact-topical anaesthesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Contact-topical anaesthesia
Trial: 14510796
Drug: Peribulbar injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peribulbar injection anaesthesia
Trial: 8970271
Drug: Dexamethasone iontophoresis
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dexamethasone iontophoresis (1 ml of DEX at 4 mg/ml mixed with 1 ml of sterile water)
Trial: 8970271
Drug: Placebo (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (2 ml of saline solution)
Trial: 6094444
Drug: No prophylactic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No prophylactic antibiotic
Trial: 27713964
Drug: Inositol-enriched beverage
RxNorm normalized name: Inositol
DrugBank: Inositol (DB13178)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Inositol-enriched beverage (IEB) (2.0 g twice a day)
Trial: 18008121
Drug: 2.5 mg
RxNorm normalized name: biotin 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg droperidol intravenously
Trial: 17459901
Drug: l‐NMMA 0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: l‐NMMA 0.15 mg/kg
Trial: 17459901
Drug: l‐NMMA 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: l‐NMMA 0.5 mg/kg
Trial: 17459901
Drug: l‐NMMA 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: l‐NMMA 1.0 mg/kg
Trial: 17459901
Drug: l‐NMMA 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: l‐NMMA 1.5 mg/kg
Trial: 11196401
Drug: Randomized Controlled
RxNorm normalized name: jojoba oil, randomized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Randomized Controlled Trials in Medicine
Trial: 8853216
Drug: Nefazodone (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nefazodone (400 mg daily)
Trial: 1535321
Drug: Inhaled ipratropium
RxNorm normalized name: ipratropium Inhalation Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled ipratropium bromide (40 micrograms)
Trial: 22541894
Drug: Twice-daily 75%/25%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice-daily 75%/25% neutral protamine lispro/lispro mix
Trial: 22541894
Drug: Once daily
RxNorm normalized name: GEL, ONCE DAILY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once daily insulin glargine
Trial: 22541894
Drug: Both insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Both insulin regimens
Trial: 15817864
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg vitamin C/d
Trial: 19057523
Drug: Lorcaserin 10
RxNorm normalized name: lorcaserin 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lorcaserin 10 mg q.d.
Trial: 19057523
Drug: Lorcaserin 15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lorcaserin 15 mg q.d.
Trial: 19057523
Drug: Lorcaserin 10
RxNorm normalized name: lorcaserin 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lorcaserin 10 mg b.i.d.
Trial: 24144215
Drug: Intravenous paracetamol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous paracetamol 15 mg/kg
Trial: 17474540
Drug: Propacetamol 30
RxNorm normalized name: Propanetriol
DrugBank: Glycerin (DB09462)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propacetamol 30 mg/kg
Trial: 8124988
Drug: Standard intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard intravenous zinc therapy
Trial: 8124988
Drug: Supplemental intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supplemental intravenous zinc therapy
Trial: 2535873
Drug: MMR vaccine
RxNorm normalized name: varicella-zoster virus vaccine live (Oka-Merck) strain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MMR vaccine with varicella vaccine
Trial: 2535873
Drug: MMR vaccine
RxNorm normalized name: varicella-zoster virus vaccine live (Oka-Merck) strain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MMR vaccine with placebo
Trial: 22581848
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg Methylphenidate (MPH)
Trial: 20836726
Drug: OC containing
RxNorm normalized name: OC 8 Adult Acne
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OC containing 35 μg ethinylestradiol plus 2 mg cyproterone acetate
Trial: 20836726
Drug: OC containing
RxNorm normalized name: OC 8 Adult Acne
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OC containing 30 μg ethinylestradiol plus 3 mg drospirenone
Trial: 20836726
Drug: Metformin 850
RxNorm normalized name: metFORMIN 850 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin 850 mg × 2
Trial: 20836726
Drug: OC treatment
RxNorm normalized name: OC 8 Adult Acne
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OC treatment (both groups A and B)
Trial: 8757208
Drug: Cetirizine 10
RxNorm normalized name: cetirizine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetirizine 10 mg once daily for 6 weeks
Trial: 1374266
Drug: Aprotinin (560
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aprotinin (560 mg; n = 10)
Trial: 27429724
Drug: Triamcinolone ointment
RxNorm normalized name: Triamcinolone
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Triamcinolone ointment and zinc-containing mouthwash
Trial: 27429724
Drug: Triamcinolone ointment
RxNorm normalized name: Triamcinolone
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Triamcinolone ointment alone
Trial: 22795360
Drug: LLPR system
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LLPR system (interactive video game-based rehabilitation) for lower limb muscle power training, 30-min training, twice a week for 6 weeks (12 sessions)
Trial: 11956124
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid at 5 mg/m2
Trial: 7697954
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg immediate-release alprazolam
Trial: 7697954
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg extended-release alprazolam
Trial: 7697954
Drug: 3 mg
RxNorm normalized name: boron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg extended-release alprazolam
Trial: 7697954
Drug: Immediate-release alprazolam
RxNorm normalized name: alprazolam Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate-release alprazolam (both doses)
Trial: 7697954
Drug: Extended-release alprazolam
RxNorm normalized name: alprazolam Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended-release alprazolam (both doses)
Trial: 385023
Drug: Labetalol (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Labetalol (600 mg/day)
Trial: 385023
Drug: Combination treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination treatment (Labetalol and Bendrofluazide)
Trial: 29040119
Drug: Biomaterial-free cultured
RxNorm normalized name: casein, emmental cultured
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biomaterial-free cultured oral mucosal epithelial cell sheets (COMECs)
Trial: 26932802
Drug: Pomalidomide 4
RxNorm normalized name: pomalidomide 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pomalidomide 4 mg on days 1 to 21 of a 28‐day cycle with weekly dexamethasone (arm B)
Trial: 26932802
Drug: Pomalidomide, dexamethasone,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pomalidomide, dexamethasone, and cyclophosphamide (PomCyDex) 400 mg orally on days 1, 8, and 15 (arm C)
Trial: 23134528
Drug: Letrozole/antagonist protocol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Letrozole/antagonist protocol (mild stimulation)
Trial: 23134528
Drug: GnRH agonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH agonist protocol (microdose flare)
Trial: 18467673
Drug: Prednisone (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone (2 mg/kg)